322
Acknowledgments
This work has been co-financed by the European Union and Greek
national funds through the program “Support for Researchers
with Emphasis on Young Researchers” (call code: EDBM34, ΚΕ
14995) and under the research title “Preparation and study of
innovative forms of administration of pharmaceutical molecules
targeting at improved pharmacological properties.”
Fig. 3 Part of
1
H NMR spectra (3.3–7.9 ppm) of (a) irbesartan dissolved in D 2 O,
(b) 2-HP-β-CD dissolved in D2O, (c) irbesartan dissolved in SDS micelles, (d)
IRB complexed with 2-HP-β-CD and dissolved in D 2 O, (e) IRB complexed with
2-HP-β-CD in SDS micelles
Dimitrios Ntountaniotis et al.
Acknowledgments
This work has been co-financed by the European Union and Greek
national funds through the program “Support for Researchers
with Emphasis on Young Researchers” (call code: EDBM34, ΚΕ
14995) and under the research title “Preparation and study of
innovative forms of administration of pharmaceutical molecules
targeting at improved pharmacological properties.”
Fig. 3 Part of
1
H NMR spectra (3.3–7.9 ppm) of (a) irbesartan dissolved in D 2 O,
(b) 2-HP-β-CD dissolved in D2O, (c) irbesartan dissolved in SDS micelles, (d)
IRB complexed with 2-HP-β-CD and dissolved in D 2 O, (e) IRB complexed with
2-HP-β-CD in SDS micelles
Dimitrios Ntountaniotis et al.